<DOC>
	<DOCNO>NCT01518985</DOCNO>
	<brief_summary>This phase 1 randomize , double-blind , 2-period , 2-sequence crossover trial enrol 6 healthy volunteer assess impact IV-administered Bendavia endothelial dysfunction induce single cigarette .</brief_summary>
	<brief_title>The Impact Intravenous Bendavia™ Endothelial Reactivity Dysfunction Cigarette Smoking</brief_title>
	<detailed_description />
	<criteria>Healthy adult male smoker 18 65 year age sign informed consent Serum sodium level lower limit site ' clinical laboratory normal range screening , D1 6 Cholesterol level ≥ 240 mg/dL Hypertension ( blood pressure SBP &gt; 140 , DBP &gt; 90 mmHg ) Body mass index &lt; 18 &gt; 32 kg/m2 , Creatinine clearance calculate Cockcroft Gault method calculate &lt; 90 mL/min , Additional laboratory abnormality determine clinically significant Principal Investigator laboratory screen Clinically significant abnormality physical examination , History evidence renal , hepatic , pulmonary ( include chronic asthma ) , endocrine ( e.g. , diabetes ) , central nervous , gastrointestinal ( include ulcer ) system dysfunction , History seizures history epilepsy , History serious ( Principal Investigator judgment ) mental illness , Receipt investigational medicinal product within 30 day prior plan date study drug administration , Positive serology human immunodeficiency virus type 1 2 , hepatitis B surface antigen , Fever &gt; 37.5°C time plan dosing , Suspicion , recent history , alcohol substance abuse , Donated blood blood product within past 30 day , Employee family member investigational site , Subjects either unwilling agree refrain use find use Nicotine ( nicotine product ) include cigarette 12 hour prior start study drug infusion completion endothelial function testing , Alcohol , Caffeine , Xanthinecontaining food beverage overthecounter medication exception Tylenol 24 hour prior dose throughout confinement period , Supplementary antioxidant vitamins 7 day prior dose throughout confinement period , Prescription medication 14 day prior 7 day post treatment Subjects previous exposure Bendavia .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>